FDA Approval of Zanidatamab - HERIZON-BTC-01 Discussion with Dr. Shubham Pant
22:00
ASH 2024 CLL Highlights - SEQUOIA, AMPLIFY, CELESTIAL
22:19
Multiple Myeloma ASH 2024 Highlights with Dr. Robert Orlowski
23:25
INAVO120 - FDA Approval of Inavolisib in Endocrine-Resistant, PIK3CA-mut, HR+ Advanced Breast Cancer
1:50:11
Les MEILLEURS CONSEILS pour ENFIN MIEUX DORMIR | EXPERT DU SOMMEIL |
26:19
2nd line treatment in advanced HCC and when to switch
27:03
Antibody Drug Conjugates: The end of chemotherapy | 2023 West Oncology Conference
56:27
CCF Webinar: A clinical trial for a potential new tHER2apy for biliary tract cancers
26:12